HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery.

AbstractOBJECTIVE:
Blood transfusions are common among patients undergoing major vascular surgery. Prior studies suggest an association between blood transfusion and increased morbidity and mortality among patients undergoing cardiac surgery. The predictors of perioperative transfusion and its impact on patients undergoing vascular surgery have been poorly defined.
METHODS:
We examined data from a large multicenter quality improvement vascular surgical registry of all patients undergoing elective or urgent open peripheral arterial disease procedures, endovascular aneurysm repair, or open abdominal aortic aneurysm (AAA) repair between January 2012 and December 2013. Emergency cases, carotid endarterectomy, and carotid artery stenting were excluded. Univariate and multivariate logistic regression modeling was used to identify predictors of transfusion and association of transfusion with outcomes. All regression models had Hosmer-Lemeshow P > .05 and area under the receiver operating characteristic curve of >0.8, confirming excellent goodness of fit and discrimination.
RESULTS:
Our study population comprised 2946 patients who underwent open peripheral arterial disease procedures (n = 1744), open AAA repair (n = 175), or endovascular aneurysm repair (n = 1027) at 22 hospitals. The overall transfusion rate was 25%, at a median nadir hemoglobin level of 7.7 g/dL. Independent factors predicting transfusion included female gender (odds ratio [OR], 2.6; 95% confidence interval [CI], 2.1-3.2), nonwhite race (OR, 2.7; 95% CI, 1.4-5.2), preoperative admission status (ie, acute care hospital) (OR, 2.6; 95% CI, 1.3-5.3), preoperative anemia (OR, 4.2; 95% CI, 3.3-5.1), congestive heart failure (OR, 1.4; 95% CI, 1.1-1.9), prior myocardial infarction (OR, 1.3; 95% CI, 1.01-1.6), clopidogrel (OR, 1.4; 95% CI, 1.2-1.8), open AAA repair (OR, 25; 95% CI, 17-39), open bypass (OR, 3.5; 95% CI, 2.7-4.6), and urgent procedures (OR, 1.4; 95% CI, 1.1-1.8). With adjustment for major covariates, perioperative transfusion was independently associated with death (OR, 6.9; 95% CI, 3.2-15), myocardial infarction (OR, 8; 95% CI, 3.7-17), and pneumonia (OR, 7.4; 95% CI, 3.3-17).
CONCLUSIONS:
Perioperative transfusion in vascular surgical patients is independently associated with increased 30-day morbidity and mortality. Given indeterminate causation, these data suggest the need for a prospective transfusion threshold study in vascular surgical patients.
AuthorsAndrea T Obi, Yeo Jung Park, Paul Bove, Robert Cuff, Andris Kazmers, Hitinder S Gurm, P Michael Grossman, Peter K Henke
JournalJournal of vascular surgery (J Vasc Surg) Vol. 61 Issue 4 Pg. 1000-9.e1 (Apr 2015) ISSN: 1097-6809 [Electronic] United States
PMID25596978 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Aneurysm (diagnosis, mortality, surgery)
  • Aortic Aneurysm, Abdominal (mortality, surgery)
  • Area Under Curve
  • Blood Loss, Surgical (mortality, prevention & control)
  • Blood Transfusion (mortality)
  • Chi-Square Distribution
  • Endovascular Procedures (adverse effects, mortality)
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Patient Selection
  • Postoperative Hemorrhage (mortality, therapy)
  • ROC Curve
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Transfusion Reaction
  • Treatment Outcome
  • United States
  • Vascular Surgical Procedures (adverse effects, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: